Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,272 total articles
Anavex Life Sciences has withdrawn its application for European marketing authorization of blarcamesine as an add-on treatment for early Alzheimer's disease after the EMA's Committee for Medicinal Products for Human Use indicated it would not issue a positive opinion at this time. The company plans to gather additional data and conduct further anal…
Creative Realities, Inc. (NASDAQ: CREX), a leading provider of digital signage and AdTech solutions, has appointed Jackie Walker as Chief Experience Officer. With over 15 years’ experience in digital transformation and expertise in retail media networks and QSR digital merchandising, Walker will lead the company’s transition into a software-first p…
Rekor Systems, a NASDAQ-listed leader in roadway intelligence systems, announced the appointment of Marc Segal as Technical Account Management Director for its Rekor Command® real-time traffic operations platform. Based in Austin, Texas, Segal's role aims to accelerate adoption and expand the platform’s presence, leveraging his expertise and existi…
Vera Therapeutics, a Nasdaq-listed biotechnology firm focused on immunological diseases, announced the appointment of Jane Wright-Mitchell as Chief Legal Officer. Wright-Mitchell brings extensive experience in legal, compliance, and regulatory affairs within life sciences, positioning the company to support key milestones and the anticipated commer…
Cipher Digital announces execution of a 15-year lease agreement for a new high-performance computing (HPC) data center campus with an investment-grade hyperscale tenant. The company also closed its first syndicated revolving credit facility of up to $200 million, enhancing liquidity and supporting growth initiatives. This strategic development rein…
HBT Financial, Inc. announced the appointment of Michael J. Morton to its Board of Directors effective April 1, 2026. Morton brings nearly 40 years of banking experience, including leadership roles at Bank of Montreal and MB Financial. This addition aims to strengthen HBT's leadership as it continues to grow its regional banking operations.
Maze Therapeutics announced positive topline results from its Phase 2 HORIZON trial showing clinical proof-of-concept for MZE829 in APOL1-mediated kidney disease (AMKD). The company plans to advance MZE829 into pivotal trials and start two Phase 2 trials in 2026 for MZE782 targeting phenylketonuria (PKU) and chronic kidney disease (CKD). Maze also …
Maze Therapeutics reported promising topline results from its Phase 2 HORIZON trial of MZE829, an oral dual-mechanism APOL1 inhibitor targeting APOL1-mediated kidney disease. Treatment resulted in a 35.6% mean reduction in proteinuria (uACR) at week 12 across a broad AMKD patient population, with enhanced efficacy in FSGS patients (61.8% reduction)…
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a significant board restructuring led by majority stockholders Inscobee Inc. and Apimeds Korea, who removed several directors and appointed new ones, including a new CEO. This followed disagreements over a prior merger with MindWave Innovations, with MindWave disputing the board chang…
Picard Medical, parent company of SynCardia Systems, reported revenue growth of 12.5% in 2025 with total revenue of $4.9 million. Despite an operating loss of $13.3 million, the company improved its operating loss and increased cash reserves significantly following successful equity and debt financing. The SynCardia Total Artificial Heart continues…
Tilray Brands, a leading global lifestyle and consumer packaged goods company in cannabis, beverages, and wellness, announced it will release its Q3 fiscal year 2026 financial results before market open on April 1, 2026, followed by a live conference call and webcast.
C4 Therapeutics has dosed the first patient in a Phase 1b trial evaluating the combination of their oral IKZF1/3 degrader cemsidomide with elranatamab (ELREXFIO®), an FDA-approved bispecific antibody, in patients with relapsed or refractory multiple myeloma. The trial aims to establish the optimal dose, assess safety, tolerability, and preliminary …
Lightbridge Corporation (Nasdaq: LTBR) has been selected to serve on the Industry Advisory Board for a $6 million Department of Energy-funded nuclear materials research project at Penn State University. The four-year BTN2M2 consortium aims to advance nuclear materials research using cutting-edge micro- and nano-scale techniques, significantly reduc…
Energous Corporation announced strong fiscal year 2025 results, reporting $5.6 million in revenue — a 633% increase from 2024 — and the lowest quarterly net loss since 2013. The company achieved four consecutive quarters of revenue growth, expanded production capacity in the U.S., and secured a large expansion with a Fortune 10 retailer. Operationa…
Garrett Motion Inc., a leader in automotive technology, announced its 2026 Technology and Investor Day on May 20, 2026, in New York City. The event will feature presentations and demonstrations on the company's turbo, zero-emission vehicle, and industrial technology portfolios, highlighting its strategic direction, financial priorities, and long-te…
Beam Therapeutics announced updated clinical data from its ongoing Phase 1/2 trial of BEAM-302, a gene-editing therapy for Alpha-1 Antitrypsin Deficiency (AATD). The therapy showed a well-tolerated safety profile and durable increases in functional AAT protein with significant reduction in mutant Z-AAT after a single dose. Beam selected 60 mg as th…
Winnebago Industries, a leading manufacturer in outdoor recreation products, reported a 6% increase in net revenues to $657.4 million for Q2 Fiscal 2026 and significant profitability improvements, including a 42.1% rise in adjusted earnings per diluted share to $0.27. The company improved operating income by 50.7% to $11.8 million and executed a $1…
Merck & Co., Inc. announced an agreement to acquire Terns Pharmaceuticals, a clinical-stage oncology company, for approximately $6.7 billion. The acquisition focuses on Terns' lead investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor, TERN-701, which is in Phase 1/2 trials for chronic myeloid leukemia (CML). The deal reflects Merck's…
Kanzhun Limited, operating as BOSS Zhipin, announced the continuation and expansion of its share repurchase program, having spent nearly RMB450 million in 2026 to buy back shares. The board increased repurchase authorization to US$400 million through August 2027 and committed to allocating at least 50% of adjusted net income annually for dividends …
PDD Holdings Inc., a US-listed e-commerce company on NASDAQ, announced its unaudited financial results for Q4 and the fiscal year 2025. The company reported a 12% revenue increase in Q4 and a 10% increase for the full year, driven by growth in online marketing and transaction services. However, net income declined by about 11%-12% due to higher ope…
NOV Inc. announced a $200 million investment to roughly double the capacity of its subsea flexible pipe manufacturing facility in Açu, Brazil, over three years. The expansion aims to satisfy strong demand driven by offshore development activity and replacement needs, with capacity currently near full utilization and backlog extending through 2028. …
ADMA Biologics, a U.S.-based biopharmaceutical company specializing in plasma-derived biologics for immune deficiencies, has publicly addressed a negative short-seller report issued by Culper Research. The company refutes the report's assertions as speculative and false, emphasizing its compliance with regulatory standards and ongoing review of the…
Amaze Holdings, Inc. issued a shareholder letter highlighting its transition from stabilizing the business in 2025 to accelerating growth in 2026. The company is focusing on expanding its Creator Commerce Flywheel by leveraging proprietary data, enhancing distribution through partnerships like the LA Times Studios integration, and scaling modular i…
Akamai Technologies has introduced Brand Guardian, an AI-driven solution designed to help enterprises proactively detect and manage brand impersonation and fraudulent digital content. By combining continuous internet monitoring with automated takedowns at 99.99% accuracy, it aims to protect sectors like financial services, retail, and healthcare fr…
Comstock Inc. announced that it will participate in a webcast presentation at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit scheduled for April 1, 2026. The company continues to focus on innovative technologies that extract and recycle critical metals from end-of-life photovoltaics, supporting clean energy systems.
